Evidence map›Paper›PMID 36250185›Full record

ArticleVeterinary medicine international2022

Waleed K Abdulsahib, Sarmed H Kathem, Mohanad Y Al-Radeef, Layth S Jasim

Open access · goldAbstract read
In one paragraph

Article in Veterinary medicine international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Essential Oils: Chemistry and Mechanisms of Anticonvulsant Action.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Effect of quercetin against pilocarpine-induced epilepsy in mice.Journal of advanced pharmaceutical technology & research
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Waleed K AbdulsahibDepartment of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-8851-5783
Sarmed H KathemDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-1346-6251
Mohanad Y Al-RadeefClinical Pharmacy Department, College of Pharmacy, Tikrit University, Tikrit, Iraq.
Layth S JasimDepartment of Chemistry, College of Education, University of Al-Qadisiyah, Diwaniya, Iraq.
University of Al-Qadisiyah · IQUniversity of Baghdad · IQUniversity of Tikrit · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Epilepsy is a progressive, chronic neurological disorder characterized by recurrent seizures. Peppermint ( Aim: We aimed to assess the potential antiepileptic and neuroprotective features of MP essential oil (MPO) in pilocarpine (P) and pentylenetetrazol (PTZ) models of epilepsy. Methods: The study used eight groups of mice to assess the anticonvulsant activity of MPO in both the P and PTZ acute models in mice. P (350 mg/kg, i.p.) was given 30 minutes after MPO (1.6, 3.2, and 6.4 ml/kg, i.p.). As a positive control group, diazepam (1 mg/kg, i.p) was used. PTZ (95 mg/kg, i.p.) was given 30 minutes after MPO (6.4 ml/kg, i.p.). The first convulsion's latency time, the number of convulsions, the latency time to death, and the percentage of deaths were calculated in all groups. Results: MPO significantly ( Conclusion: MPO at 3.2 and 6.4 ml/kg doses can reduce the percentage and the number of convulsions and increase the latency time of both the first convulsion and death so that it can be used as a supplement in the treatment of epilepsy.

Identifiers

PMID36250185
PMCPMC9553835
OpenAlexW4297894159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.